伐尼地平 T24932

Product Introduction
Bioactivity


英文名: Vatanidipine

描述: Vatanidipine (AE0047) 是一种新型的双氢吡啶(DHP)型钙通道阻滞剂，具有缓慢起效的药理作用。在各种实验性高血压模型中观察到缓慢起效和持久的降压作用。

体内活性: Vatanidipine (AE0047 ) (10 and 50 ng/kg/min) was administered intrarenally, increases in the basal renal blood flow and urine formation were observed. During Vatanidipine (50 ng/kg/min) infusion, low-frequency RNS-induced antidiuretic action and increase in NESR were markedly attenuated. In addition, high-frequency RNS-induced renal vasoconstriction was significantly suppressed by Vatanidipineinfusion at higher doses. Lower doses of Vatanidipine (10 ng/kg/min) tended to attenuate the low- and high-frequency RNS-induced antidiuretic actions, although neither of the RNS-induced increases in NESR were suppressed by lower doses of Vatanidipine[2].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 27.5 mg/mL (40.04 mM)


关键字: Vatanidipine

相关产品: Ionomycin calcium | Fasudil hydrochloride | Methyl 3,4,5-trimethoxycinnamate | 1-Hydroxy-2,3,5-trimethoxyxanthone | YM-244769 dihydrochloride | 1-Octanol | A 839977 | Atagabalin HCl | Equilin | Lifarizine

相关库: Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Neuronal Signaling Compound Library | Bioactive Compound Library

伐尼地平 T24932信息由TargetMol中国为您提供，如您想了解更多关于伐尼地平 T24932报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途